The BSTC chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BSTC chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BSTC stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BSTC Detailed Price Forecast - CNN Money||View BSTC Detailed Summary - Google Finance|
|View BSTC Detailed Summary - Yahoo! Finance||View BSTC Stock Research & Analysis - Zacks.com|
|View BSTC Trends & Analysis - Trade-Ideas||View BSTC Major Holders - Barrons|
|View BSTC Call Transcripts - NASDAQ||View BSTC Breaking News & Analysis - Seeking Alpha|
|View BSTC Annual Report - CompanySpotlight.com||View BSTC OTC Short Report - OTCShortReport.com|
|View BSTC Fundamentals - TradeKing||View BSTC SEC Filings - Bar Chart|
|View Historical Prices for BSTC - The WSJ||View Performance/Total Return for BSTC - Morningstar|
|View the Analyst Estimates for BSTC - MarketWatch||View the Earnings History for BSTC - CNBC|
|View the BSTC Earnings - StockMarketWatch||View BSTC Buy or Sell Recommendations - MacroAxis|
|View the BSTC Bullish Patterns - American Bulls||View BSTC Short Pain Metrics - ShortPainBot.com|
|View BSTC Stock Mentions - StockTwits||View BSTC Stock Mentions - PennyStockTweets|
|View BSTC Stock Mentions - Twitter||View BSTC Investment Forum News - Investor Hub|
|View BSTC Stock Mentions - Yahoo! Message Board||View BSTC Stock Mentions - Seeking Alpha|
|View Insider Transactions for BSTC - SECform4.com||View Insider Transactions for BSTC - Insider Cow|
|View BSTC Major Holdings Summary - CNBC||View Insider Disclosure for BSTC - OTC Markets|
|View Insider Transactions for BSTC - Yahoo! Finance||View Institutional Holdings for BSTC - NASDAQ|
|View BSTC Stock Insight & Charts - FinViz.com||View BSTC Investment Charts - StockCharts.com|
|View BSTC Stock Overview & Charts - BarChart||View BSTC User Generated Charts - Trading View|
New Research: Key Drivers of Growth for CNB Financial, Akebia Therapeutics, Mesoblast, 21Vianet Group, Old Line Bancshares, and BioSpecifics Technologies — Factors of Influence, Major Initiatives and Sustained Production
Posted on Friday March 16, 2018
NEW YORK, March 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
BioSpecifics posts 4Q profit
Posted on Wednesday March 14, 2018
On a per-share basis, the Lynbrook, New York-based company said it had profit of 36 cents. Earnings, adjusted for pretax expenses, were 51 cents per share. The biopharmaceutical company posted revenue ...
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
Posted on Wednesday March 14, 2018
LYNBROOK, N.Y. , March 14, 2018 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first ...
BioSpecifics Technologies Corp. Announces Presentation of Interim Data from Phase 1 Study of CCH for the Treatment of Uterine Fibroids at 65th Annual Scientific Meeting of the Society for Reproductive Investigation
Posted on Monday March 12, 2018
LYNBROOK, N.Y., March 12, 2018 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced the presentation of interim data from its ongoing Phase 1 trial of Collagenase Clostridium Histolyticum (CCH) for the treatment of uterine fibroids at the 65th Annual Scientific Meeting of the Society for Reproductive Investigation on Friday, March 9, 2018 in San Diego, CA. The data show the safety and effectiveness of the CCH injection method in five patients. "These interim data are very encouraging and show not only a significant reduction of collagen content but also the disruption of the tissue pattern in the uterine fibroids injected with CCH," said Thomas L. Wegman, President of BioSpecifics.